Gotham Asset Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,267
Closed -$304K 1156
2020
Q2
$304K Buy
+3,267
New +$180K 0.01% 860

Other funds holding VBIV

Gotham Asset Management's VBIV Position: Q3 2020 in Review

Gotham Asset Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2020, closing a stake of 3,267 shares — an estimated $304K sold.

Gotham Asset Management first reported a position in VBIV in Q2 2020 and held it in 1 quarter. The position peaked at $304K in Q2 2020. 114 funds tracked by Wall St. Rank hold VBIV as of Q3 2020.

  • Gotham Asset Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2020 after selling out during the quarter.
  • Gotham Asset Management sold 3,267 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2020, an estimated $304K.
  • Gotham Asset Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2020 and held it in 1 quarter.
  • Gotham Asset Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $304K in Q2 2020.
  • 114 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2020.

Based on Gotham Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.